|
1
|
Kumar A and Cannon CP: Acute coronary
syndromes: Diagnosis and management, part I. Mayo Clin Proc. 84:pp.
917–938. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnett CF and De Marco T: Pulmonary
hypertension associated with left-sided heart disease. Heart Fail
Clin. 8:447–459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toldo S, Bogaard HJ, Van Tassell BW,
Mezzaroma E, Seropian IM, Robati R, Salloum FN, Voelkel NF and
Abbate A: Right ventricular dysfunction following acute myocardial
infarction in the absence of pulmonary hypertension in the mouse.
PLoS One. 6:e181022011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galiè N, Hoeper MM, Humbert M, Torbicki A,
Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS,
et al: Guidelines for the diagnosis and treatment of pulmonary
hypertension: The task force for the diagnosis and treatment of
pulmonary hypertension of the european society of cardiology (ESC)
and the european respiratory society (ERS), endorsed by the
international society of heart and lung transplantation (ISHLT).
Eur Heart J. 30:2493–2537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gajarsa JJ and Kloner RA: Left ventricular
remodeling in the post-infarction heart: A review of cellular,
molecular mechanisms, and therapeutic modalities. Heart Fail Rev.
16:13–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lundgren J and Rådegran G: Pathophysiology
and potential treatments of pulmonary hypertension due to systolic
left heart failure. Acta Physiol (Oxf). 211:314–333. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vachiéry JL, Adir Y, Barberà JA, Champion
H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, et
al: Pulmonary hypertension due to left heart diseases. J Am Coll
Cardiol. 62 25 Suppl:D100–D108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galie N, Humbert M, Vachiery JL, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf A Vonk,
Beghetti M, et al: 2015 ESC/ERS Guidelines for the diagnosis and
treatment of pulmonary hypertension. The Joint Task Force for the
Diagnosis and Treatment of Pulmonary Hypertension of the European
Society of Cardiology (ESC) and the European Respiratory Society
(ERS). Eur Respir J. 46:903–975. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ignarro LJ: Nitric oxide as a unique
signaling molecule in the vascular system: A historical overview. J
Physiol Pharmacol. 53:503–514. 2002.PubMed/NCBI
|
|
10
|
Ignarro LJ, Buga GM, Wood KS, Byrns RE and
Chaudhuri G: Endothelium-derived relaxing factor produced and
released from artery and vein is nitric oxide. Proc Natl Acad Sci
USA. 84:pp. 9265–9269. 1987; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Napoli C and Ignarro LJ: Nitric oxide and
pathogenic mechanisms involved in the development of vascular
diseases. Arch Pharm Res. 32:1103–1108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blum M, Yachnin T, Wollman Y, Chernihovsky
T, Peer G, Grosskopf I, Kaplan E, Silverberg D, Cabili S and Iaina
A: Low nitric oxide production in patients with chronic renal
failure. Nephron. 79:265–268. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt RJ and Baylis C: Total nitric
oxide production is low in patients with chronic renal disease.
Kidney Int. 58:1261–1266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Neye N, Enigk F, Shiva S, Habazettl H,
Plesnila N, Kuppe H, Gladwin MT and Kuebler WM: Inhalation of NO
during myocardial ischemia reduces infarct size and improves
cardiac function. Intensive Care Med. 38:1381–1391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghofrani HA, Galiè N, Grimminger F, Grünig
E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A,
et al: Riociguat for the treatment of pulmonary arterial
hypertension. N Engl J Med. 369:330–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dejam A, Hunter CJ, Tremonti C, Pluta RM,
Hon YY, Grimes G, Partovi K, Pelletier MM, Oldfield EH, Cannon RO
III, et al: Nitrite infusion in humans and nonhuman primates:
Endocrine effects, pharmacokinetics, and tolerance formation.
Circulation. 116:1821–1831. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puikuan K, Chunyu Z, Jin F, Chaoshu T and
Junbao D: Inhalation of nebulized nitroglycerin, a nitric oxide
donor, for the treatment of pulmonary hypertension induced by high
pulmonary blood flow. Heart Vessels. 21:169–179. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia HP, Huang GY, Zhu JX and Sun B: Effect
of inhalation of nebulized NO donor substance on acute hypoxic lung
injury in newborn piglets. Chin Med J (Engl). 121:1622–1626.
2008.PubMed/NCBI
|
|
19
|
Horinaka S, Kobayashi N, Yagi H, Mori Y
and Matsuoka H: Nicorandil but not ISDN upregulates endothelial
nitric oxide synthase expression, preventing left ventricular
remodeling and degradation of cardiac function in Dahl
salt-sensitive hypertensive rats with congestive heart failure. J
Cardiovasc Pharmacol. 47:629–635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cohn JN, Tam SW, Anand IS, Taylor AL,
Sabolinski ML and Worcel M: A-HeFT Investigators: Isosorbide
dinitrate and hydralazine in a fixed-dose combination produces
further regression of left ventricular remodeling in a well-treated
black population with heart failure: Results from A-HeFT. J Card
Fail. 13:331–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
National Research Council (US), . Guide
for the Care and Use of Laboratory Animals. 8th. National Academies
Press (US); Washington, DC: 2011, PubMed/NCBI
|
|
22
|
Zornoff LA, Paiva SA, Minicucci MF and
Spadaro J: Experimental myocardium infarction in rats: Analysis of
the model. Arq Bras Cardiol. 93:434–440, 426-432. 2009.(In English,
Portuguese, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Horie M, Yoshiura Y, Izumi H, Oyabu T,
Tomonaga T, Okada T, Lee BW, Myojo T, Kubo M, Shimada M and
Morimoto Y: Comparison of the pulmonary oxidative stress caused by
intratracheal instillation and inhalation of NiO nanoparticles when
equivalent amounts of NiO are retained in the lung. Antioxidants
(Basel). 5(pii): E42016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stefanon I, Valero-Muñoz M, Fernandes AA,
Ribeiro RF Jr, Rodríguez C, Miana M, Martínez-González J, Spalenza
JS, Lahera V, Vassallo PF and Cachofeiro V: Left and right
ventricle late remodeling following myocardial infarction in rats.
PLoS One. 8:e649862013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi S, Liang J, Liu T, Yuan X, Ruan B, Sun
L, Tang Y, Yang B, Hu D and Huang C: Depression increases
sympathetic activity and exacerbates myocardial remodeling after
myocardial infarction: Evidence from an animal experiment. PLoS
One. 9:e1017342014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Q, Sun C, Xu X, Zhou J, Wu Y, Tian Y,
Yuan Z and Liu Z: CD34+ cell mobilization and upregulation of
myocardial cytokines in a rabbit model of myocardial ischemia. Int
J Cardiol. 152:18–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reichenbach A, Al-Hiti H, Malek I, Pirk J,
Goncalvesova E, Kautzner J and Melenovsky V: The effects of
phosphodiesterase 5 inhibition on hemodynamics, functional status
and survival in advanced heart failure and pulmonary hypertension:
A case-control study. Int J Cardiol. 168:60–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jasmin JF, Mercier I, Hnasko R, Cheung MW,
Tanowitz HB, Dupuis J and Lisanti MP: Lung remodeling and pulmonary
hypertension after myocardial infarction: Pathogenic role of
reduced caveolin expression. Cardiovasc Res. 63:747–755. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Tassell BW, Bhardwaj HL, Grizzard JD,
Kontos MC, Bogaard H, Gomez-Arroyo J, Toldo S, Mezzaroma E, Voelkel
NF and Abbate A: Right ventricular systolic dysfunction in patients
with reperfused ST-segment elevation acute myocardial infarction.
Int J Cardiol. 155:314–316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abd-Elmoniem KZ, Tomas MS, Sasano T,
Soleimanifard S, Vonken EJ, Youssef A, Agarwal H, Dimaano VL,
Calkins H, Stuber M, et al: Assessment of distribution and
evolution of mechanical dyssynchrony in a porcine model of
myocardial infarction by cardiovascular magnetic resonance. J
Cardiovasc Magn Reson. 14:12012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Drakos SG, Kfoury AG, Selzman CH, Verma
DR, Nanas JN, Li DY and Stehlik J: Left ventricular assist device
unloading effects on myocardial structure and function: Current
status of the field and call for action. Curr Opin Cardiol.
26:245–255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
George RS, Birks EJ, Cheetham A, Webb C,
Smolenski RT, Khaghani A, Yacoub MH and Kelion A: The effect of
long-term left ventricular assist device support on myocardial
sympathetic activity in patients with non-ischaemic dilated
cardiomyopath. Eur J Heart Fail. 15:1035–1043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Samson R, Baydoun H, Jaiswal A and Le
Jemtel TH: Cardiac adrenergic nervous system and left ventricular
remodeling. Am J Med Sci. 350:321–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haider N, Baliga RR, Chandrashekhar Y and
Narula J: Adrenergic excess, hNET1 down-regulation, and compromised
mIBG uptake in heart failure poverty in the presence of plenty.
JACC Cardiovasc Imaging. 3:71–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai M, Ren L, Yin X, Guo Z, Li Y, He T,
Tang Y, Long T, Liu Y, Liu G, et al: PET monitoring angiogenesis of
infarcted myocardium after treatment with vascular endothelial
growth factor and bone marrow mesenchymal stem cells. Amino Acids.
48:811–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang R, Wang L, Zhang L, Chen J, Zhu Z,
Zhang Z and Chopp M: Nitric oxide enhances angiogenesis via the
synthesis of vascular endothelial growth factor and cGMP after
stroke in the rat. Circ Res. 92:308–313. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rammos C, Luedike P, Hendgen-Cotta U and
Rassaf T: Potential of dietary nitrate in angiogenesis. World J
Cardiol. 7:652–657. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun X, Li J, Zhao W, Lu S, Guo C, Lai H
and Wang C: Early assistance with left ventricular assist device
limits left ventricular remodeling after acute myocardial
infarction in a swine model. Artif Organs. 40:243–251. 2016.
View Article : Google Scholar : PubMed/NCBI
|
